These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11449629)

  • 1. [Development and use of anti-epithelial antibodies in solid tumors].
    Müller P; Schlimok G
    Internist (Berl); 2001 Jun; 42(6):827-34. PubMed ID: 11449629
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization effect of monoclonal antibodies against tumor-associated antigens during cancer treatment.
    Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
    Ann N Y Acad Sci; 1993 Aug; 690():337-9. PubMed ID: 8368748
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the colorectal antigen IOR C2.II.
    Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
    Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting targeted therapies.
    Shingler W; Harrop R
    Immunotherapy; 2010 Nov; 2(6):745-8. PubMed ID: 21091104
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncologic theranostics: recognition of this concept in antigen-directed cancer therapy for colorectal cancer with anti-TAG-72 monoclonal antibodies.
    Povoski SP; Hatzaras IS; Mojzisik CM; Martin EW
    Expert Rev Mol Diagn; 2011 Sep; 11(7):667-70. PubMed ID: 21902525
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of monoclonal antibodies in the treatment of solid tumors].
    Moiseenko VM
    Vopr Onkol; 1999; 45(4):458-62. PubMed ID: 10532114
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical studies: solid tumors.
    Spitler LE
    Cancer Treat Res; 1988; 37():493-514. PubMed ID: 2908641
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibody may increase survival rate in patients with colorectal cancer.
    Oncology (Williston Park); 1998 Sep; 12(9):1350. PubMed ID: 9778682
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor targeting with monoclonal antibody B72.3.
    Schlom J; Colcher D; Roselli M; Carrasquillo JA; Reynolds JC; Larson SM; Sugarbaker P; Tuttle SE; Martin EW
    Int J Rad Appl Instrum B; 1989; 16(2):137-42. PubMed ID: 2654088
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor vaccination using monoclonal antibodies].
    Veelken H
    Internist (Berl); 2001 Jun; 42(6):874-83. PubMed ID: 11449634
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic monoclonal antibodies: introduction.
    Ferrone S
    Semin Oncol; 2014 Oct; 41(5):556-8. PubMed ID: 25440602
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
    Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
    Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
    [No Abstract]   [Full Text] [Related]  

  • 13. Ga733/EpCAM as a target for passive and active specific immunotherapy in patients with colorectal carcinoma.
    Mellstedt H; Fagerberg J; Frödin JE; Hjelm-Skog AL; Liljefors M; Markovic K; Mosolits S; Ragnhammar P
    Ann N Y Acad Sci; 2000 Jun; 910():254-61; discussion 261-2. PubMed ID: 10911918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors.
    Schlom J; Colcher D; Szpak CA; Johnston WW; Sugarbaker P; Carrasquillo JA; Reynolds JC; Larson SM
    Prog Clin Biol Res; 1989; 288():63-72. PubMed ID: 2717642
    [No Abstract]   [Full Text] [Related]  

  • 15. "But Dr. Old, we already have an antibody!" Reflections on Lloyd Old's "academic biotech" approach for targeted antibodies.
    Ritter G
    Cancer Immun; 2012; 12():9. PubMed ID: 22896754
    [No Abstract]   [Full Text] [Related]  

  • 16. [Can monoclonal antibodies to a carcinoma-specific cell surface molecule prevent liver metastasis of human colorectal carcinoma and effectively treat already existing micrometastases?].
    Burkart C; Porschen R
    Z Gastroenterol; 1996 Jan; 34(1):41-2. PubMed ID: 8776175
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.
    Zbar AP; Thomas H; Wilkinson RW; Wadhwa M; Syrigos KN; Ross EL; Dilger P; Allen-Mersh TG; Kmiot WA; Epenetos AA; Snary D; Bodmer WF
    Int J Colorectal Dis; 2005 Sep; 20(5):403-14. PubMed ID: 15864608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction of monoclonal anti Leu M1--a myelomonocytic marker (CD15)--with normal and neoplastic epithelia.
    Sewell HF; Jaffray B; Thompson WD
    J Pathol; 1987 Apr; 151(4):279-84. PubMed ID: 2438392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-idiotype vaccine against cancer.
    Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
    Immunol Lett; 2000 Sep; 74(1):51-8. PubMed ID: 10996628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meeting highlights: 5th Annual International Congress on Monoclonal Antibodies in Cancer, August 2005, Quebec City, Canada.
    Reddy GK
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):71-6. PubMed ID: 16231842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.